Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
CASE REPORT
Year : 2020  |  Volume : 18  |  Issue : 3  |  Page : 245-247

Imatinib mesylate-induced pemphigus foliaceus in a patient with gastrointestinal stromal tumor


1 Department of Dermatology, Bangalore Baptist Hospital, Bengaluru, Karnataka, India
2 Department of Haemato-Oncology, Bangalore Baptist Hospital, Bengaluru, Karnataka, India
3 Department of Medical Oncology, Bangalore Baptist Hospital, Bengaluru, Karnataka, India
4 Department of Surgical Oncology, Bangalore Baptist Hospital, Bengaluru, Karnataka, India

Correspondence Address:
Dr. Priya Jeevamani Chandrasekaran
Department of Dermatology, Bangalore Baptist Hospital, Bengaluru - 560 024, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/cmi.cmi_25_20

Rights and Permissions

Imatinib mesylate is a tyrosine kinase inhibitor approved for treatment of gastrointestinal stromal tumors and chronic myeloid leukemia. Several cutaneous adverse reactions have been reported with its use. There are a very few reports of imatinib induced bullous disorders. We report a case of pemphigus foliaceus associated with imatinib mesylate therapy in a patient with gastrointestinal stromal tumor.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed242    
    Printed27    
    Emailed0    
    PDF Downloaded37    
    Comments [Add]    

Recommend this journal